PROFECTUS BIOSCIENCES, INC

Profile

Company Names

PROFECTUS BIOSCIENCES, INC
PROFECTUS BIOSCIENCES INC

Addresses

6411 BECKLEY STREET, BALTIMORE, MD 21224

6411 BECKLEY STREET, SUITE N202, BALTIMORE, MD 21224

6411 BECKLEY STREET, SUITE N201, BALTIMORE, MD 21224

Phone Numbers

443-743-1100

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$14,882,412.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2016-05-05 
$300,000.00 
$4,000,000.00 
$3,700,000.00 
 
2
2009-07-20 
$7,541,206.00 
$7,541,206.00 
$0.00 
Equity 
1
2009-07-17 
$7,041,206.00 
$7,041,206.00 
$0.00 
Equity, Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
BRIAN 
 
ADAMSKY 
DIRECTOR
BRIAN 
K. 
ADAMSKY 
DIRECTOR
JOSEPH 
 
BERARDINO 
DIRECTOR
MICHAEL 
 
GREENEBAUM 
DIRECTOR
MICHAEL 
J. 
GREENEBAUM 
DIRECTOR
STEWART 
 
GREENEBAUM 
DIRECTOR
STEWART 
J. 
GREENEBAUM 
DIRECTOR
WILLIAM 
 
HASELTINE 
DIRECTOR
WILLIAM 
HASELTINE 
DIRECTOR
WILLIAM 
A. 
HASELTINE 
DIRECTOR
REINHARD 
 
KURTH 
DIRECTOR
REINHARD 
A. 
KURTH 
DIRECTOR
TERRY 
 
LIERMAN 
DIRECTOR
THOMAS 
LYNCH 
DIRECTOR
THOMAS 
A. 
LYNCH 
DIRECTOR, EXECUTIVE OFFICER
JEFFREY 
 
MESHULAM 
EXECUTIVE OFFICER
JEFFREY 
N. 
MESHULAM 
EXECUTIVE OFFICER, DIRECTOR
SHAWN 
PATRICK 
O-BRIEN 
EXECUTIVE OFFICER, DIRECTOR
THOMAS 
G. 
PAESE 
DIRECTOR, EXECUTIVE OFFICER
THOMAS 
G. 
PEASE 
EXECUTIVE OFFICER, DIRECTOR
TOM 
 
PEASE 
EXECUTIVE OFFICER
ALEXANDER 
 
RICH 
DIRECTOR
ALEXANDER 
G. 
RICH 
DIRECTOR, EXECUTIVE OFFICER
M.G. 
 
SARNGADHARAN 
DIRECTOR
M.G. 
 
SARNGAHARAN 
DIRECTOR, EXECUTIVE OFFICER
JEFFREY 
 
STELLO 
EXECUTIVE OFFICER
FREDERICK 
C. 
TECCE 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2016-05-05 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2016-05-05 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-07-20 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2009-07-20 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-07-20 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2009-07-17 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2009-07-17 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-07-20 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-07-20 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#